Whilst insulin resistance both in peripheral tissues and within the liver contributes to this, the evidence from studies looking at PNPLA3 demonstrates that insulin resistance is not an absolute requirement for the development NAFLD. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.